| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 11/15/1993 | CA2095404A1 Purification and characterization of a csvtcg-specific tumor cell adhesion receptor |
| 11/15/1993 | CA2068695A1 Methods and compositions for treatment of virus infections |
| 11/12/1993 | CA2095888A1 Methods for detecting beta amyloid precursor protein processing enzyme |
| 11/11/1993 | WO1993022685A1 Evaluative means for detecting inflammatory reactivity |
| 11/11/1993 | WO1993022450A1 Novel diphtheria toxin-based molecules |
| 11/11/1993 | WO1993022449A1 Inhibitory factor |
| 11/11/1993 | WO1993022448A1 Fed batch culture method for protein secreting cells |
| 11/11/1993 | WO1993022447A1 Novel polypeptide |
| 11/11/1993 | WO1993022443A1 In vivo homologous sequence targeting in eukaryotic cells |
| 11/11/1993 | WO1993022442A1 Oral infection of insect larvae with pre-occluded baculovirus particles |
| 11/11/1993 | WO1993022437A1 New polypeptides and peptides, nucleic acids coding for them, and their use in the field of tumor therapy, inflammation or immunology |
| 11/11/1993 | WO1993022436A1 Lectin domain variants of selectin |
| 11/11/1993 | WO1993022434A2 Targeted cleavage of rna using eukaryotic ribonuclease p and external guide sequence |
| 11/11/1993 | WO1993022433A2 Medicament for the gene-therapeutic treatment of human beings, animals and plants, especially to block virus multiplication and carcinogenes and process for producing the medicament |
| 11/11/1993 | WO1993022430A1 Development of a vector to target gene expression to the epidermis of transgenic animals |
| 11/11/1993 | WO1993022429A1 Novel compositions and methods for detection and treatment of human osteoarthritis |
| 11/11/1993 | WO1993022424A1 RECOMBINANT STIMULATING FACTOR OF THE neu RECEPTOR |
| 11/11/1993 | WO1993022349A1 NATURAL HUMAN IgM ANTIBODIES |
| 11/11/1993 | WO1993022348A1 Production of recombinant human lactoferrin |
| 11/11/1993 | WO1993022346A1 A novel anti-neoplastic cytokine |
| 11/11/1993 | WO1993022344A1 Peptide derivatives corresponding to the carboxy terminal sequence of hirudin |
| 11/11/1993 | WO1993022342A1 Protein l and hybrid proteins thereof |
| 11/11/1993 | WO1993022340A1 Modulation of thrombospondin-cd36 interactions |
| 11/11/1993 | WO1993022339A1 BINDING PEPTIDES WHICH INTERACT WITH LIGAND GROWTH FACTORS OF THE EPIDERMAL GROWTH FACTOR RECEPTOR AND erbB-2-RECEPTOR |
| 11/11/1993 | WO1993022338A1 Peptides of human papilloma virus for use in human t cell response inducing compositions |
| 11/11/1993 | WO1993022336A1 Improved solubilization and stabilization of factor viii complex |
| 11/11/1993 | WO1993022335A1 Stable polypeptide composition |
| 11/11/1993 | WO1993021959A1 Bystander effect tumoricidal therapy |
| 11/11/1993 | WO1993021956A1 Antibodies to p-selectin and their uses |
| 11/11/1993 | WO1993021954A1 Slip1/sulfated-glyco moiety interfering compositions and methods for inhibition of fertilization |
| 11/11/1993 | WO1993021953A1 Composition for prophylaxis and treatment of pulmonary fibrosis |
| 11/11/1993 | WO1993021948A1 Peptide-carbohydrate conjugates generating t-cell immunity |
| 11/11/1993 | WO1993021947A1 Improved production of reproductive hormones |
| 11/11/1993 | WO1993021946A1 Methods for treating interleukin-1 and tumor necrosis factor mediated diseases |
| 11/11/1993 | WO1993021945A1 METHODS FOR TREATING VASCULAR DISORDERS BY INHIBITING THE ENDOTHELIN STIMULATORY ACTIVITY OF TGF$g(b) |
| 11/11/1993 | WO1993021944A1 Methods of treating cancer using modified c-reactive protein |
| 11/11/1993 | WO1993021943A1 Antiviral agent comprising cd4 and an h2 histone |
| 11/11/1993 | WO1993021942A2 Use of mmp inhibitors |
| 11/11/1993 | WO1993021941A1 Treatment of herpesvirus infection |
| 11/11/1993 | WO1993021940A1 Intraoperative, intravascular and endoscopic tumor and lesion detection and therapy |
| 11/11/1993 | WO1993021939A1 Method of treating cancer |
| 11/11/1993 | WO1993021938A1 Methods for treating cancer using high-dose epirubicin |
| 11/11/1993 | WO1993021937A1 Non-bitter protein hydrolyzates |
| 11/11/1993 | WO1993021936A1 LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF |
| 11/11/1993 | WO1993021934A1 Heteropolytungstates in the treatment of flavivirus infections |
| 11/11/1993 | WO1993021911A1 Method and means for preventing constriction of the pupil in the eye |
| 11/11/1993 | WO1993021905A1 Bioadhesive solid mineral oil emulsion |
| 11/11/1993 | WO1993021769A1 Diphtheria toxin receptor-binding region |
| 11/11/1993 | WO1993020238A3 Amplification of human mdm2 gene in human tumors |
| 11/11/1993 | WO1993018163A3 Delivery and expression of a hybrid surface protein on the surface of gram positive bacteria |
| 11/11/1993 | WO1993018159A3 Compositions and methods for pace 4 and 4.1 gene and polypeptides in cells |
| 11/11/1993 | WO1993017712A3 Conjugates formed from heat shock proteins and oligo- or polysaccharides |
| 11/11/1993 | WO1993017691A3 Pharmaceutical compositions containing monosialoganglioside gm1 or a derivative thereof suitable for the treatment of parkinson's disease |
| 11/11/1993 | WO1993001169A3 Aromatic compounds, pharmaceutical compositions containing them and their use in therapy |
| 11/11/1993 | CA2135052A1 Diphtheria toxin receptor-binding region |
| 11/11/1993 | CA2134877A1 Heteropolytungstates in the treatment of flavivirus infection |
| 11/11/1993 | CA2134763A1 Bystander effect tumoricidal therapy |
| 11/11/1993 | CA2134675A1 Development of a vector to target gene expression to the epidermis of transcenic animals |
| 11/11/1993 | CA2134655A1 Modulation of thrombospondin-cd36 interactions |
| 11/11/1993 | CA2134564A1 Recombinant stimulating factor of the neu receptor |
| 11/11/1993 | CA2134544A1 Binding peptides which interact with ligand growth factors of the epidermal growth factor receptor and erbb-2 receptor |
| 11/11/1993 | CA2134447A1 Collagen-containing sponges as drug delivery for proteins |
| 11/11/1993 | CA2134443A1 Inhibitory factor |
| 11/11/1993 | CA2134119A1 Treatment of herpesvirus infection |
| 11/11/1993 | CA2134097A1 Peptide-carbohydrate conjugates generating t-cell immunity |
| 11/11/1993 | CA2134073A1 Bioadhesive aqueous mineral oil emulsion ointment base, topical pharmaceutical compositions comprising same and their use in wound healing |
| 11/11/1993 | CA2133581A1 Peptide derivatives corresponding to the carboxy terminal sequence of hirudin |
| 11/11/1993 | CA2133580A1 Intraoperative, intravascular and endoscopic tumor and lesion detection and therapy |
| 11/11/1993 | CA2118513A1 In vivo homologous sequence targeting in eukaryotic cells |
| 11/11/1993 | CA2118320A1 Production of reproductive hormones |
| 11/11/1993 | CA2118128A1 Non-bitter protein hydrolyzates |
| 11/11/1993 | CA2112798A1 Peptides of human papilloma virus for use in human t cell response inducing compositions |
| 11/11/1993 | CA2111561A1 Fed batch culture method for protein secreting cells |
| 11/10/1993 | EP0569141A2 Methods of inhibiting the growth of multidrug resistant tumors with an antibody |
| 11/10/1993 | EP0569042A1 Medical uses of IL-1 beta |
| 11/10/1993 | EP0568925A2 TNF receptor action modulation |
| 11/10/1993 | EP0568833A1 Human antithrombin III mutants |
| 11/10/1993 | EP0568687A1 Novel amylin antagonist peptides and uses therefor |
| 11/10/1993 | EP0568645A1 Mixed specificity fusion proteins |
| 11/10/1993 | EP0568631A1 Monoclonal antibodies to elam-1 and their uses |
| 11/10/1993 | EP0568623A1 Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations |
| 11/10/1993 | EP0568622A1 CORTICOTROPIN RELEASING FACTOR BINDING PROTEIN (CRF-bp) |
| 11/10/1993 | EP0568575A1 Test and model for alzheimer's disease |
| 11/10/1993 | EP0568539A1 Soluble mannose receptor peptides |
| 11/10/1993 | EP0568537A1 Genetic modification of endothelial cells |
| 11/10/1993 | EP0552302A4 Method of inhibiting transcription utilizing nuclear receptors |
| 11/10/1993 | EP0516704B1 Novel insulin compositions |
| 11/09/1993 | US5260432 Genetic engineering |
| 11/09/1993 | US5260421 Site-directed mutagenesis modified glycoprotein hormones |
| 11/09/1993 | US5260420 Concentrate of thrombin coagulable proteins, the method of obtaining same and therapeutical use thereof |
| 11/09/1993 | US5260417 Megakaryocyte growth promoting activity protein |
| 11/09/1993 | US5260416 Antigenic epitopes present on membrane-bound but not secreted IgE |
| 11/09/1993 | US5260321 Cardiovascular disorders |
| 11/09/1993 | US5260308 Proteins glycated with glucose |
| 11/09/1993 | US5260282 Saliva substitute |
| 11/09/1993 | US5260280 Sialyllactose |
| 11/09/1993 | US5260278 Diol-containing renin inhibitors |
| 11/09/1993 | US5260277 Cell receptor antagonists |
| 11/09/1993 | US5260276 Hypotensive agents, treatment of myocardial infraction, congestive heart failure, endotoxic shock, antiarrythmia agents |
| 11/09/1993 | US5260275 Glibenclamide and tolbutamide for treating non-insulin dependent, or type 2, diabetes mellitus; enhance plasma concentration of amylin |